Lilly 1Q 1Q Revenues: $5.5 billion (+9%) 1Q Earnings: $1.2 billion (-5%) Comments:Total revenue in the U.S. was up 6% to $3.0 billion and outside the U.S. increased 13% to $2.5 billion. Zyprexa sales were $1.2 billion (+8%). Cymbalta sales were $803.2 million (+13%). Alimta sales were $527.4 million (+57%). Humalog sales were up 12% to $506.4 million. Cialis sales were $408.3 million (+14%). Gemzar sales were down 22% to $287.8 million, due to the entry of generic competition in some m...